218 related articles for article (PubMed ID: 26596021)
1. [Treatment research progress on the treatment of neurofibromatosis type 2-associated vestibular schwannoma].
Zhao Y; Yang Q; Jiang Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 May; 29(10):955-8. PubMed ID: 26596021
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis type 2 vestibular schwannoma treatment: a review of the literature, trends, and outcomes.
Maniakas A; Saliba I
Otol Neurotol; 2014 Jun; 35(5):889-94. PubMed ID: 24675066
[TBL] [Abstract][Full Text] [Related]
3. Targeted Therapies in the Treatment of Vestibular Schwannomas: Current State and New Horizons.
Welling DB
Otolaryngol Clin North Am; 2023 Jun; 56(3):543-556. PubMed ID: 37024334
[TBL] [Abstract][Full Text] [Related]
4. Preservation of auditory and vestibular function after surgical removal of bilateral vestibular schwannomas in a patient with neurofibromatosis type 2.
Black FO; Brackmann DE; Hitselberger WE; Purdy J
Am J Otol; 1995 Jul; 16(4):431-43. PubMed ID: 8588642
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
Sun S; Liu A
J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
[TBL] [Abstract][Full Text] [Related]
6. Controversies in building a management algorithm for vestibular schwannomas.
Doherty JK; Friedman RA
Curr Opin Otolaryngol Head Neck Surg; 2006 Oct; 14(5):305-13. PubMed ID: 16974142
[TBL] [Abstract][Full Text] [Related]
7. Bilateral intracochlear schwannomas in a patient with no genetic or clinical features of neurofibromatosis type 2.
Withers S; Plontke SK; Boeddinghaus R; Kuthubutheen J; Atlas M
HNO; 2020 Jan; 68(Suppl 1):60-64. PubMed ID: 31598774
[TBL] [Abstract][Full Text] [Related]
8. Vestibular Schwannoma Excision in Sporadic versus Neurofibromatosis Type 2 Populations.
Mahboubi H; Maducdoc MM; Yau AY; Ziai K; Ghavami Y; Badran KW; Al-Thobaiti M; Brandon B; Djalilian HR
Otolaryngol Head Neck Surg; 2015 Nov; 153(5):822-31. PubMed ID: 25791708
[TBL] [Abstract][Full Text] [Related]
9. Management of Neurofibromatosis Type 2-Associated Vestibular Schwannomas.
Jiramongkolchai P; Schwartz MS; Friedman RA
Otolaryngol Clin North Am; 2023 Jun; 56(3):533-541. PubMed ID: 36964092
[TBL] [Abstract][Full Text] [Related]
10. Acoustic neuroma.
Consens Statement; 1991 Dec 11-13; 9(4):1-24. PubMed ID: 1840823
[TBL] [Abstract][Full Text] [Related]
11. [Bilateral intracochlear schwannomas in a patient with no genetic or clinical features of neurofibromatosis type 2. German version].
Withers S; Plontke SK; Boeddinghaus R; Kuthubutheen J; Atlas M
HNO; 2020 Jul; 68(7):534-538. PubMed ID: 31758201
[TBL] [Abstract][Full Text] [Related]
12. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
[TBL] [Abstract][Full Text] [Related]
13. Radiobiology of vestibular schwannomas: mechanisms of radioresistance and potential targets for therapeutic sensitization.
Yeung AH; Sughrue ME; Kane AJ; Tihan T; Cheung SW; Parsa AT
Neurosurg Focus; 2009 Dec; 27(6):E2. PubMed ID: 19951055
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2.
Choi JW; Lee JY; Phi JH; Wang KC; Chung HT; Paek SH; Kim DG; Park SH; Kim SK
J Neurosurg Pediatr; 2014 Jun; 13(6):650-7. PubMed ID: 24724714
[TBL] [Abstract][Full Text] [Related]
15. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Emerging Therapies for the Treatment of Patients With Vestibular Schwannomas.
Van Gompel JJ; Agazzi S; Carlson ML; Adewumi DA; Hadjipanayis CG; Uhm JH; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E52-E54. PubMed ID: 29309638
[TBL] [Abstract][Full Text] [Related]
16. Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models.
Zhao Y; Liu P; Zhang N; Chen J; Landegger LD; Wu L; Zhao F; Zhao Y; Zhang Y; Zhang J; Fujita T; Stemmer-Rachamimov A; Ferraro GB; Liu H; Muzikansky A; Plotkin SR; Stankovic KM; Jain RK; Xu L
Proc Natl Acad Sci U S A; 2018 Feb; 115(9):E2077-E2084. PubMed ID: 29440379
[TBL] [Abstract][Full Text] [Related]
17. Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: clinical and molecular study of a unique phenotype.
Aghi M; Kluwe L; Webster MT; Jacoby LB; Barker FG; Ojemann RG; Mautner VF; MacCollin M
J Neurosurg; 2006 Feb; 104(2):201-7. PubMed ID: 16509493
[TBL] [Abstract][Full Text] [Related]
18. Vestibular schwannoma: role of conservative management.
Suryanarayanan R; Ramsden RT; Saeed SR; Aggarwal R; King AT; Rutherford SA; Evans DG; Gillespie JE
J Laryngol Otol; 2010 Mar; 124(3):251-7. PubMed ID: 20003606
[TBL] [Abstract][Full Text] [Related]
19. Non surgical treatment of vestibular schwannoma.
Arribas L; Chust ML; Menéndez A; Arana E; Vendrell JB; Crispín V; Pesudo C; Mengual JL; Mut A; Arribas M; Guinot JL
Acta Otorrinolaringol Esp; 2015; 66(4):185-91. PubMed ID: 25497840
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis type 2.
Slattery WH
Otolaryngol Clin North Am; 2015 Jun; 48(3):443-60. PubMed ID: 26043141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
